Although it is well established that the tumour-protective and anti-proliferative effect of progesterone on the endometrial epithelium [14] is mediated via progesterone receptor (PR) activity in the endometrial stroma (and not directly via epithelial PR) [15], very little is known about early molecular changes that contribute to the development of this disease. Here, PGR is linked to neoplasm.